DZ540A1 - Composés bicycliques. - Google Patents

Composés bicycliques.

Info

Publication number
DZ540A1
DZ540A1 DZ836846A DZ836846A DZ540A1 DZ 540 A1 DZ540 A1 DZ 540A1 DZ 836846 A DZ836846 A DZ 836846A DZ 836846 A DZ836846 A DZ 836846A DZ 540 A1 DZ540 A1 DZ 540A1
Authority
DZ
Algeria
Prior art keywords
bicyclic compounds
bicyclic
compounds
Prior art date
Application number
DZ836846A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DZ540A1 publication Critical patent/DZ540A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/04—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/409—Compounds containing the structure P(=X)-X-acyl, P(=X) -X-heteroatom, P(=X)-X-CN (X = O, S, Se)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650905—Six-membered rings having the nitrogen atoms in the positions 1 and 2
    • C07F9/650947—Six-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
DZ836846A 1982-05-12 1983-05-10 Composés bicycliques. DZ540A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8213850 1982-05-12
GB08305505A GB2128984B (en) 1982-05-12 1983-02-28 Diaza-bicyclic compounds

Publications (1)

Publication Number Publication Date
DZ540A1 true DZ540A1 (fr) 2004-09-13

Family

ID=26282820

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ836846A DZ540A1 (fr) 1982-05-12 1983-05-10 Composés bicycliques.

Country Status (32)

Country Link
US (3) US4512924A (fr)
EP (1) EP0094095B1 (fr)
KR (1) KR890002106B1 (fr)
AR (1) AR240940A1 (fr)
AU (1) AU567873B2 (fr)
BG (1) BG61123B2 (fr)
CA (1) CA1234568A (fr)
CS (2) CS249128B2 (fr)
CU (1) CU21532A3 (fr)
DE (2) DE3317290A1 (fr)
DK (1) DK160612C (fr)
DO (1) DOP1983004163A (fr)
DZ (1) DZ540A1 (fr)
ES (6) ES8407049A1 (fr)
FI (1) FI77244C (fr)
FR (1) FR2531956B1 (fr)
GB (1) GB2128984B (fr)
GR (1) GR77462B (fr)
HK (1) HK91692A (fr)
HU (3) HU198935B (fr)
IE (1) IE56480B1 (fr)
IL (1) IL68620A (fr)
IT (1) IT1212738B (fr)
LU (2) LU84803A1 (fr)
MC (1) MC1515A1 (fr)
MY (1) MY102889A (fr)
NL (2) NL8301640A (fr)
NO (1) NO160368C (fr)
PT (1) PT76681B (fr)
SE (1) SE461792B (fr)
SG (1) SG81192G (fr)
ZW (1) ZW9883A1 (fr)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA833214B (en) * 1982-05-12 1983-12-28 Hoffmann La Roche Bicyclic compounds
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
DE3315464A1 (de) * 1983-04-28 1984-10-31 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern
US4801721A (en) * 1984-08-16 1989-01-31 Ryan James W Stereospecific synthesis of carboxyalkyl peptides
US4692438A (en) * 1984-08-24 1987-09-08 Hoffmann-La Roche Inc. Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US4902707A (en) * 1985-04-30 1990-02-20 Eli Lilly And Company Bicyclic pyrazolidinones, compositions and use
US4826992A (en) * 1985-04-30 1989-05-02 Eli Lilly And Company 2,3-(Dihydro) bicyclic pyrazolidinones
ES8801833A1 (es) * 1985-04-30 1988-02-16 Lilly Co Eli Un procedimiento para la preparacion de un compuesto.
US4940718A (en) * 1985-04-30 1990-07-10 Eli Lilly And Company 7-substituted bicyclic pyrazolidinones, pharmaceutical compositions and use
ZW11586A1 (en) * 1985-07-01 1987-12-30 Hoffmann La Roche Bicyclic compounds
US4832763A (en) * 1985-10-15 1989-05-23 Westinghouse Electric Corp. Method of stress-relief annealing a magnetic core containing amorphous material
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
EP0254032A3 (fr) * 1986-06-20 1990-09-05 Schering Corporation Inhibiteurs de la métallo-endopeptidase neutre dans le traitement de l'hypertension
EP0566157A1 (fr) 1986-06-20 1993-10-20 Schering Corporation Inhibiteurs de la métallo-Endopeptidase neutre dans le traitement de l'hypertension
GB8629875D0 (en) * 1986-12-15 1987-01-28 Hoffmann La Roche Pyridazodiazepine derivatives
US5262436A (en) * 1987-03-27 1993-11-16 Schering Corporation Acylamino acid antihypertensives in the treatment of congestive heart failure
US4956490A (en) * 1989-03-09 1990-09-11 Merck & Co., Inc. Process for preparing benzylpyruvic acids and esters
ZA902661B (en) * 1989-04-10 1991-01-30 Schering Corp Mercapto-acyl amino acids
DE3917255A1 (de) * 1989-05-26 1990-11-29 Schopf Masch Verfahren und vorrichtung zum aufnehmen eines flugzeugbugfahrwerks durch einen flugzeugschlepper
US5011938A (en) * 1989-10-02 1991-04-30 Eli Lilly And Company 7-substituted bicyclic pyrazolidinones
WO1991007386A1 (fr) * 1989-11-21 1991-05-30 Schering Corporation Acides amines de carboxyalkylcarbonyle inhibiteurs d'endopeptidases
WO1991009840A1 (fr) * 1989-12-22 1991-07-11 Schering Corporation Inhibiteurs aminoacides mercaptocycloacyliques d'endopeptidase
US5075302A (en) * 1990-03-09 1991-12-24 Schering Corporation Mercaptoacyl aminolactam endopeptidase inhibitors
US5173506A (en) * 1990-08-16 1992-12-22 Schering Corporation N-(mercaptoalkyl)ureas and carbamates
DE59107840D1 (de) * 1990-11-21 1996-06-27 Ciba Geigy Ag Silylierte Acylphosphinoxide
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
BR9205752A (pt) * 1991-03-19 1994-11-08 Ciba Geigy Ag Novos compostos herbicidamente, acaricidamente e inseticidamente ativos
TW216770B (fr) * 1991-07-23 1993-12-01 Hoffmann La Roche
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
ZA927211B (en) * 1991-09-27 1993-03-24 Merrell Dow Pharma Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE.
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
JPH06107661A (ja) * 1991-10-24 1994-04-19 Upjohn Co:The イミダゾール誘導体およびこれを有効成分とする医薬組成物
US5442062A (en) * 1991-10-24 1995-08-15 The Upjohn Company Imidazole derivatives and pharmaceutical compositions containing the same
US5972990A (en) * 1992-04-10 1999-10-26 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
US5977160A (en) * 1992-04-10 1999-11-02 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
US5646276A (en) * 1992-05-13 1997-07-08 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
ES2138622T3 (es) * 1992-05-15 2000-01-16 Merrell Pharma Inc Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
ES2164056T3 (es) * 1992-05-18 2002-02-16 Hoffmann La Roche Hidrogenacion asimetrica.
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
HUT71243A (en) * 1992-10-30 1995-11-28 Merrell Pharma Inc Mercaptoacetylamide bicyclic lactam derivatives, process for producing them and pharmaceutical compositions of enkephalinase and ace inhibitor activity containing said compounds
JPH072859A (ja) * 1993-01-28 1995-01-06 Upjohn Co:The ピラゾール誘導体およびこれを有効成分とする医薬組成物
US5476395A (en) * 1993-03-01 1995-12-19 Methode Electronics, Inc. Planar fuse panel
DE59409631D1 (de) * 1993-07-15 2001-02-15 Hoffmann La Roche Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
JPH09508906A (ja) * 1994-02-14 1997-09-09 メレル ファーマスーティカルズ インコーポレーテッド エンケファリナーゼ及びａｃｅの阻害剤として有用な新規なメルカプトアセチルアミド１，３，４，５−テトラヒドロベンゾ［ｃ］アゼピン−３−オンジスルフィド誘導体類
EP0745080B1 (fr) * 1994-02-14 1999-03-03 Merrell Pharmaceuticals Inc. Nouveaux derives bisulfure de mercaptoacetylamides utiles comme inhibiteurs de l'enkephalinase et de l'enzyme de conversion de l'angiotensine (ace)
WO1995021857A1 (fr) * 1994-02-14 1995-08-17 Merrell Pharmaceuticals Inc. Nouveaux derives bisulfure d'idane-2-mercaptoacetylamides substitues en position 2, utiles comme inhibiteurs de l'encephalinase et de l'enzyme de conversion de l'angiotensine (ace)
WO1995021840A1 (fr) * 1994-02-14 1995-08-17 Merrell Pharmaceuticals Inc. Nouveaux derives de bisulfure d'indane-2-mercaptoacetylamide utiles en tant qu'inhibiteurs de l'encephalinase
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
CN1144487A (zh) * 1994-03-24 1997-03-05 默里尔药物公司 降低胆固醇、抗动脉粥样硬化和降低甘油三酯的巯基乙酰胺衍生物
ATE246927T1 (de) * 1994-03-24 2003-08-15 Merrell Pharma Inc Cholesterin senkende mercaptoacetylamiddisulfidderivate
US5756466A (en) 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
AU2003200034B2 (en) * 1998-04-27 2006-07-20 Aventis Pharma S.A. New derivatives of octahydro-6, 10-dioxo-6H-pyridazino [1,2-A][1,2]diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds
FR2777888B1 (fr) * 1998-04-27 2004-07-16 Hoechst Marion Roussel Inc Nouveaux derives de l'acide (3,4,7,8,9,10-hexahydro-6,10- dioxo-6h-pyridazino[1,2-a][1,2]diazepine-1-carboxylique, leur procede de preparation et leur application a la preparation de medicaments
FR2777889B1 (fr) * 1998-04-27 2004-07-09 Hoechst Marion Roussel Inc Nouveaux derives de l'acide octahydro-6,10-dioxo-6h- pyridazino[1,2-a][1,2]diazepine-1-carboxylique, leur procede de preparation et leur application a la preparation de composes therapeutiquement actifs
US6177565B1 (en) * 1998-08-19 2001-01-23 Vertex Pharmaceuticals Inc. Process for synthesizing piperazic acid
US6703500B2 (en) 1998-08-19 2004-03-09 Vertex Pharmaceuticals, Incorporated Method of preparing bicyclic intermediates from piperazic acid or an ester thereof useful in the manufacture of caspase inhibitors
US6559304B1 (en) * 1998-08-19 2003-05-06 Vertex Pharmaceuticals Incorporated Method for synthesizing caspase inhibitors
FR2788276B1 (fr) 1999-01-12 2001-02-16 Hoechst Marion Roussel Inc NOUVEAU PROCEDE DE PREPARATION DE COMPOSES BICYCLIQUES ET L'APPLICATION DE CE PROCEDE COMME ETAPE INTERMEDIAIRE POUR LA PREPARATION D'UN COMPOSE INHIBITEUR DE L'ENZYME DE CONVERSION DE L'INTERLEUKINE 1-BETA (ice)
EP1216037A2 (fr) * 1999-09-21 2002-06-26 Emory University Procedes et compositions pour le traitement de troubles lies aux plaquettes au moyen d'agents inhibiteurs de trajet de mpl
US20030113330A1 (en) * 1999-11-08 2003-06-19 Uhal Bruce D. Methods for treating pulmonary fibrosis
EP1386165B1 (fr) 2000-12-14 2011-11-02 The Brigham And Women's Hospital, Inc. Marqueurs inflammatoires comme outils de detection et de prevention du diabete sucre et comme outils facilitant la selection d'agents s'utilisant dans la prevention et le traitement du diabete
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use
DK3072978T3 (en) 2002-05-09 2018-09-17 Brigham & Womens Hospital Inc : 1L1RL-1 AS A CARDIOVASCULAR DISEASE MARKER
US20040110241A1 (en) * 2002-12-06 2004-06-10 Segal Mark S. Materials and methods for monitoring vascular endothelial function
JP2006523613A (ja) * 2002-12-20 2006-10-19 エスティ．ジェイムス アソシエイト エルエルシー／フェイバー リサーチ シリーズ 徐放性医薬投与のための被覆粒子
US20060293517A1 (en) * 2003-03-06 2006-12-28 Yatendra Kumar Enantiomerically pure cilazapril, process for preparation
WO2005003134A1 (fr) * 2003-07-07 2005-01-13 Hetero Drugs Limited Procede d'elaboration de cilazapril
US7491743B2 (en) 2003-08-29 2009-02-17 President And Fellows Of Harvard College Inhibitors of cellular necrosis
ATE546734T1 (de) 2003-12-05 2012-03-15 Cleveland Clinic Foundation Risikomarker für eine herzkreislaufkrankheit
US7803838B2 (en) * 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
WO2005122682A2 (fr) 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Procede de preparation d'esters d'acide piperazique
CA2624601C (fr) 2004-10-06 2018-07-03 The Brigham And Women's Hospital, Inc. Pertinence de niveaux obtenus de marqueurs d'inflammation generalisee a la suite d'un traitement
US20080306041A1 (en) * 2005-01-21 2008-12-11 Garvey David S Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
EP1848424B1 (fr) * 2005-01-31 2017-04-05 Mylan Laboratories, Inc Preparation pharmaceutique comprenant du nebivolol hydroxyle
EP1890691A2 (fr) 2005-05-31 2008-02-27 Mylan Laboratories, Inc Compositions a base de nebivolol
US8119358B2 (en) 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
US20070281000A1 (en) * 2006-06-02 2007-12-06 Michael Fox Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
DK1864677T3 (da) 2006-06-02 2008-04-28 Teva Pharma Stabil formulering omfattende et fugtsensitivt lægemiddel og fremstillingsmetoder deraf
WO2007146229A2 (fr) 2006-06-07 2007-12-21 Tethys Bioscience, Inc. Marqueurs associés à des événements artério-vasculaires et procédés d'utilisation de ces marqueurs
US20080008751A1 (en) * 2006-07-10 2008-01-10 Michael Fox Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
JP5271350B2 (ja) 2007-04-18 2013-08-21 テシス バイオサイエンス， インコーポレイテッド 糖尿病に関連するバイオマーカーおよびその使用方法
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
EP2221299A3 (fr) 2009-02-11 2010-11-03 Dr. Reddy's Laboratories Ltd. Préparation d'intermédiaires du cilazapril
TW201201764A (en) 2010-02-01 2012-01-16 Hospital For Sick Children Remote ischemic conditioning for treatment and prevention of restenosis
SG10201908570RA (en) 2010-03-31 2019-11-28 Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction
CA2800520A1 (fr) 2010-04-08 2011-10-13 The Hospital For Sick Children Utilisation du conditionnement ischemique a distance pour une lesion traumatique
WO2012049646A1 (fr) 2010-10-12 2012-04-19 Ranbaxy Laboratories Limited Procédé de préparation d'un intermédiaire de cilazapril
EP2537534B1 (fr) 2011-06-22 2014-12-17 Hexal AG Esters d'acide (1S,9S)-9-[[(1S)-1-carboxy-3-phénylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazépine-1-carboxylique et leur utilisation thérapeutique
EP3173093B1 (fr) 2011-07-18 2018-12-05 Critical Care Diagnostics, Inc. Méthodes de traitement de maladies cardiovasculaires et de prédiction de l'efficacité d'une gymnastique rééducative
US9265772B2 (en) 2012-05-11 2016-02-23 Reset Therapeutics, Inc. Carbazole-containing sulfonamides as cryptochrome modulators
EP2879666B1 (fr) 2012-08-01 2020-04-08 Tavakoli, Zahra Compositions congelées à écoulement libre comprenant un agent thérapeutique
US9725452B2 (en) 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
SG11201507751YA (en) 2013-03-21 2015-10-29 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
TWI690521B (zh) 2014-04-07 2020-04-11 美商同步製藥公司 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
TW201720427A (zh) 2015-10-27 2017-06-16 優普順藥物股份有限公司 局部麻醉劑之持續釋放調配物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL60617A0 (en) * 1979-07-23 1980-09-16 Sparamedica Ag Triazolopyridazine derivative,their preparation and pharmaceutical compositions containing them
DE3062972D1 (en) * 1979-09-19 1983-06-09 Hoffmann La Roche Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives
EP0042100A1 (fr) * 1980-06-13 1981-12-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Dérivés de la pyrazolopyridazine, intermédiaires et leur procédés de préparation, et médicaments les contenant
EP0047620B1 (fr) * 1980-09-10 1985-03-13 Beecham Group Plc Aryl amides diazabicycliques, procédé pour leur préparation et leur application
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds

Also Published As

Publication number Publication date
KR890002106B1 (ko) 1989-06-19
EP0094095B1 (fr) 1990-09-19
ES8800170A1 (es) 1987-11-01
PT76681A (en) 1983-06-01
MY102889A (en) 1993-03-31
SE8302716D0 (sv) 1983-05-11
DK194783A (da) 1983-11-13
ES522291A0 (es) 1984-08-16
GB8305505D0 (en) 1983-03-30
AR240940A1 (es) 1991-03-27
NO160368C (no) 1989-04-12
GR77462B (fr) 1984-09-24
CS249128B2 (en) 1987-03-12
NO160368B (no) 1989-01-02
ES528625A0 (es) 1985-05-16
US4512924A (en) 1985-04-23
HU198935B (en) 1989-12-28
DK194783D0 (da) 1983-05-02
FI77244C (fi) 1989-02-10
US4658024A (en) 1987-04-14
EP0094095A3 (en) 1984-11-21
LU88299I2 (fr) 1994-09-09
KR840004754A (ko) 1984-10-24
DE3317290A1 (de) 1983-11-17
DOP1983004163A (es) 1988-09-20
IE831084L (en) 1983-11-12
HK91692A (en) 1992-11-27
HU199842B (en) 1990-03-28
DK160612B (da) 1991-04-02
CS402191A3 (en) 1992-10-14
ES8505173A1 (es) 1985-05-16
IL68620A0 (en) 1983-09-30
AU567873B2 (en) 1987-12-10
ES8407049A1 (es) 1984-08-16
ES528628A0 (es) 1987-07-16
US4772701A (en) 1988-09-20
SE461792B (sv) 1990-03-26
MC1515A1 (fr) 1984-02-10
BG61123B2 (bg) 1996-11-29
FI831661L (fi) 1983-11-13
HU195965B (en) 1988-08-29
EP0094095A2 (fr) 1983-11-16
IE56480B1 (en) 1991-08-14
IT8321000A0 (it) 1983-05-09
ES8601994A1 (es) 1985-11-16
NL930055I2 (nl) 1993-10-01
AR240940A2 (es) 1991-03-27
NL8301640A (nl) 1983-12-01
FI77244B (fi) 1988-10-31
ZW9883A1 (en) 1984-11-21
DE3381884D1 (de) 1990-10-25
NO831675L (no) 1983-11-14
PT76681B (en) 1986-05-20
IL68620A (en) 1987-11-30
LU84803A1 (fr) 1985-03-21
GB2128984B (en) 1985-05-22
ES554935A0 (es) 1987-11-01
CU21532A3 (en) 1987-06-09
ES528630A0 (es) 1986-06-16
DK160612C (da) 1991-09-23
IT1212738B (it) 1989-11-30
SG81192G (en) 1993-01-29
SE8302716L (sv) 1983-11-13
CA1234568A (fr) 1988-03-29
AU1436483A (en) 1983-11-17
GB2128984A (en) 1984-05-10
FR2531956B1 (fr) 1987-02-20
NL930055I1 (nl) 1993-09-01
ES8706672A1 (es) 1987-07-16
FR2531956A1 (fr) 1984-02-24
ES528627A0 (es) 1985-11-16
ES8607970A1 (es) 1986-06-16
FI831661A0 (fi) 1983-05-12

Similar Documents

Publication Publication Date Title
DZ540A1 (fr) Composés bicycliques.
FI834235A (fi) Anordning foer placering av koniska foeremaol i en laoda.
FI834261A (fi) Paosliknande saeckar foer foervaring av vaetskor.
FI824215L (fi) Foerfarande foer upploesning av cellulosakarbamat.
FI841294A0 (fi) Foerfarande foer aostadkommande av foerbaettringar i boskapskoetsel.
FI834397A (fi) Lindning av cellulosabanor.
FI834454A (fi) Foerfarande foer upparbetning av komplexa sulfidiska malmkoncentrat.
FI823929L (fi) Odlingsgrupp foer skolning av plantor.
FI834735A (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat.
FI842596A (fi) Foerfarande foer bildande av permanentvaogor i haoret.
FI834238A (fi) Foerfarande foer framstaellning av citrussaftkoncentrat.
FI834231A (fi) Enzymatisk syntes av l-serin.
FI834372A (fi) Foerbindning av skidsko.
FI833864A (fi) Staell foer lagring av kaernbraensle- element.
FI834382A (fi) Foerfarande foer delignifierande blekning av cellulosamassa.
FI834259A (fi) Foerfarande foer framstaellning av optiskt aktiva cyanometylestrar.
IT8219187A0 (it) Composti biciclici.
FI73996B (fi) Foerfarande foer framstaellning av ergolinderivat.
FI74015B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla vinyltioacetamidooxakefalosporinderivat.
FI834849A0 (fi) Foerfarande foer framstaellning av en behaollare, saerskilt foer transformatorer
FI73491B (fi) Foerbindelsedel foer tvao byggnadselement av staolbetong.
FI74022B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva antracyklinglykosider.
FI834340A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara svavelhaltiga bensylidenderivat.
FI842860A0 (fi) Anlaeggning foer buntning av tidningar.
FI834627A (fi) Foerfarande foer haerdning av jaernlegeringar i vattenhaltig omgivning.